跳至主要内容
临床试验/ACTRN12617000186358
ACTRN12617000186358已完成未知

Immunological Effects of Andrographis paniculata in healthy adult males

Integria Healthcare (Australia) Pty Ltd.0 个研究点目标入组 20 人开始时间: 2017年2月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 未提供

研究者

相似试验

已完成
1 期
Study the effects of Andrographis paniculata on platelet aggregation in Thai healthy volunteers: the pilot studyhealthy human volunteers
TCTR20141128001Faculty of Medicine Siriraj Hospital10
尚未招募
4 期
A clinical study to understand the combined effects of Andrographis & metformin, in comparison to metformin alone treatment on glycemic control in type 2 diabetes patients
CTRI/2019/11/021977Dr Anand Kumar Maurya
已完成
3 期
The efficacy and safety of Andrographis paniculata extract for the treatment of acute nonspecific upper respiratory tract infections: a randomized double-blind placebo controlled trialAcute nonspecific upper respiratory tract infections with one or more symptoms such as fever&#44sore throat&#44nasal congestion&#44dry infrequent cough and had modified Centor Score of 2 or less.Andrographis paniculataandrographolideacute nonspecific upper respiratory tract infectionspharyngitiscommon cold
TCTR20170329002Department of Thai Traditional and Alternative Medicine829
已完成
2 期
Efficacy of Andrographis paniculata spray in acute pharyngitisAcute viral pharyngitisAndrographis paniculata, acute viral pharyngitis, sore throat, plant extract, spray
TCTR20230915005Abhaiphubet Chaopraya Hospital Foundation60
已完成
2 期
Efficacy of Andrographis paniculata extract Combined with Favipiravir Treatment to Prevent Disease Progression in mild to moderate COVID-19 Patients: A Double-blind, Randomized, Placebo-Controlled StudyMild to moderate COVID-19andrographolides, COVID-19, SARS-CoV-2, andrographis panniculata, favipiravir
TCTR20210609001Chulabhorn Royal Academy146
An investigation into the immunomodulating effects... | 临床试验